Development of a Quantitative Real-Time RT-PCR Assay for the Detection of MAGE-A3–Positive Tumors
In conclusion, we have developed a MAGE-A3–specific RT-qPCR assay, compatible with a high-throughput setting for the estimation of MAGEA3 gene expression in present and future clinical trials.
Source: The Journal of Molecular Diagnostics - Category: Pathology Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Genetics | Immunotherapy | Melanoma | Pathology | Skin Cancer